Keryx kidney disease drug meets late-stage trial goal

(Reuters) - Keryx Biopharmaceuticals Inc said a late-stage trial of its experimental drug for kidney disease met the main study goal of reducing phosphate levels in blood, sending the company's shares up as much as 49 percent. The level of pho...

Source: http://health.yahoo.net/news/s/nm/keryx-kidney-disease-drug-meets-late-stage-trial-goal

for more info site website view